| Literature DB >> 35926570 |
Katie Coakley1, Laura Friedman2, Kaitlyn McLoughlin2, Amy Wozniak2, Paul Hutchison2.
Abstract
OBJECTIVE: To describe the function of patients with COVID-19 admitted to an acute care hospital early in the pandemic and to characterize change in function among those admitted to intensive care units (ICU) and to non-critical care services.Entities:
Keywords: Acute rehabilitation; COVID-19; Occupational therapy; Physical therapy; Rehabilitation
Year: 2022 PMID: 35926570 PMCID: PMC9340124 DOI: 10.1016/j.apmr.2022.07.010
Source DB: PubMed Journal: Arch Phys Med Rehabil ISSN: 0003-9993 Impact factor: 4.060
Figure 1Patient cohorts by therapy and ICU status.
Patient Demographics and Comorbidities by Therapy and ICU status.
| Age, Mean (SD) | 54 (16) | 68 (16) | |||
| Male | 238 (55) | 92 (54) | 57 (59) | 26 (48) | 63 (57) |
| Race | |||||
| White | 202 (47) | 77 (45) | 46 (48) | 19 (35) | 60 (54) |
| Black | 120 (28) | 50 (29) | 25 (26) | 22 (41) | 23 (21) |
| Other | 108 (25) | 43 (25) | 25 (26) | 13 (24) | 27 (25) |
| Hispanic | 210 (50) | 89 (53) | 50 (55) | 13 (25) | 58 (54) |
| Chronic Lung Disease | 73 (17) | 28 (17) | 15 (16) | 13 (25) | 17 (16) |
| Diabetes | 197 (47) | 66 (40) | 46 (51) | 28 (53) | 57 (52) |
| Cardiovascular Disease | 287 (68) | 96 (57) | 69 (76) | 46 (87) | 76 (69) |
| Renal Disease | 77 (18) | 24 (14) | 17 (19) | 12 (23) | 24 (22) |
| Liver Disease | 23 (5) | 8 (5) | 6 (7) | 5 (9) | 4 (4) |
| Immunosuppressive Comorbidity | 42 (10) | 17 (10) | 11 (12) | 4 (8) | 10 (9) |
| Neurologic Comorbidity | 56 (13) | 14 (8) | 16 (17) | 10 (19) | 16 (15) |
| Cancer | 33 (8) | 11 (7) | 8 (9) | 8 (15) | 6 (6) |
| Current Smoker | 17 (5) | 7 (5) | 0 (0) | 4 (8) | 6 (6) |
Missingness: Age 2, Gender 2, Race 2, Ethnicity 13, Chronic Lung Disease, 14, Diabetes 13, Cardiovascular Disease 11, Liver Disease 12, Renal Disease 12, Immunosuppressive Comorbidity 15, Neurologic Comorbidity 12, Cancer 15, Current Smoker 58.
Therapy details by ICU status
| None | 29 (18) | 16 (30) | 13 (12) |
| 1-4x/week | 82 (50) | 33 (61) | 49 (44) |
| 4-5x/week, 1-3x/day | 54 (33) | 5 (9) | 49 (44) |
| None | 8 (5) | 4 (7) | 4 (4) |
| 1-4x/week | 60 (36) | 27 (50) | 33 (30) |
| 4-5x/week, 1-3x/day | 97 (59) | 23 (43) | 74 (67) |
| Impaired cognition | 97 (59) | 23 (43) | 74 (67) |
| Impaired strength | 113 (68) | 30 (56) | 83 (75) |
| Impaired proximal strength | 102 (64) | 25 (48) | 77 (72) |
| Impaired distal strength | 79 (50) | 19 (37) | 60 (56) |
| Impaired balance | 144 (87) | 48 (89) | 96 (86) |
| Impaired activity tolerance | 158 (96) | 50 (94) | 108 (97) |
| Impaired sensation | 18 (11) | 9 (17) | 9 (8) |
| Impaired coordination | 57 (35) | 15 (28) | 42 (38) |
| Impaired proprioception | 12 (7) | 3 (6) | 9 (8) |
| Therapy recommended at discharge | 123 (76) | 37 (71) | 86 (78) |
Missingness: Cognition 1, Proximal strength 6, Distal strength 6, Activity Tolerance 1, Coordination 1, Therapy recommended at discharge 3,
Functional Outcome Measures by ICU Status
| Therapy, No ICU | AM-PAC Basic Mobility, Raw | 17.1 (4.3), n=51 | 17.9 (4.1), n=36 | 1.0 (2.3)*, n=35 |
| AM-PAC Basic Mobility, t-Scale Score | 43.3 (7.9), n=51 | 44.8 (8.0), n=36 | 2.0 (4.9)*, n=35 | |
| AM-PAC Daily Activity, Raw | 17.1 (3.9), n=42 | 16.7 (3.7), n=18 | 0.7 (2.0), n=18 | |
| AM-PAC Daily Activity, t-Scale Score | 37.9 (6.6), n=42 | 37.2 (5.7), n=18 | 1.2 (3.4), n=18 | |
| Therapy, ICU | FSS-ICU | 9.0 (7.3), n=82 | 10.6 (6.6), n=67 | 2.5 (5.6)*, n=66 |
| AM-PAC Basic Mobility, Raw | 14.1 (5.4), n=79 | 16.7 (5.7), n=72 | 2.8 (3.9)*, n=69 | |
| AM-PAC Basic Mobility, t-Scale Score | 38.4 (9.6), n=79 | 43.3 (10.7), n=72 | 5.2 (7.2)*, n=69 | |
| AM-PAC Daily Activity, Raw | 15.4 (4.3), n=65 | 16.4 (4.0), n=51 | 1.2 (3.3)* n=48 | |
| AM-PAC Daily Activity, t-Scale Score | 35.7 (7.3), n=65 | 36.8 (7.0), n=51 | 1.6 (5.4)*, n=48 | |
*Paired t-test difference (Post-Pre) significantly different from zero (0), p <.05
Patient Interventions and Discharge Destinations by Therapy and ICU Status
| Ever Mechanically Ventilated | 144 (33) | – | 64 (67) | – | 80 (72) |
| If ever mechanically ventilated, Total Days Median (Q1, Q3) | 12 (5, 22) | – | 10 (4, 17) | – | 13.5 (6, 23.5) |
| Ever on ECMO | 6 (1) | – | 0 (0) | – | 6 (5) |
| If ever on ECMO, Total Days, Median (Q1, Q3) | 2.5 (1, 5) | – | – | – | 2.5 (1, 5) |
| Ever Paralyzed with Neuromuscular Blockade | 77 (37) | – | 35 (36) | – | 42 (38) |
| If ever paralyzed, Total Days, Median (Q1, Q3) | 3 (1, 6) | – | 2 (1, 6) | – | 3 (2, 6) |
| Length of Stay, Median (Q1, Q3) | 7 (3, 17) | 3 (2, 5) | 10 (6, 18) | 6 (3, 9) | 22 (13.5, 37) |
| Died in Hospital | 82 (19) | 1 (1) | 61 (64) | 1 (2) | 19 (17) |
| Discharge Location* | |||||
| • Home, Home w/ Help, Home Health care, Outpatient therapy | 261 (75) | 161 (95) | 24 (69) | 36 (68) | 40 (43) |
| • Long-term care facility | 15 (4) | 7 (4) | 4 (4) | 3 (6) | 1 (1) |
| • Acute inpatient rehabilitation or Skilled Nursing Facility/Subacute rehabilitation | 50 (14) | 1 (1) | 1 (3) | 14 (26) | 34 (37) |
| • Other: LTACH, Transfers | 24 (7) | 1 (1) | 6 (17) | 0 (0) | 17 (18) |
* Column percentages based on those discharged, excluding those who died in hospital